Checks immunity to measles, mumps, rubella and varicella from a single blood sample. Suited to anyone wanting a combined check across all four infections rather than testing them separately.
4 biomarkers as listed by Blue Horizon Medicals.
This test measures IgG antibody levels for measles, mumps, rubella and varicella. These antibody levels are commonly used to assess whether someone has developed immunity to these infections, whether through past infection or vaccination.
Against the 24 similarly sized immunity tests we track, this profile's four biomarkers place it in the 87th percentile for clinical depth, among the broadest in the group. Its £120.25 price is around 21% above the £99.13 median for that group, making it one of the pricier options despite the strong biomarker count. Like other profiles in Blue Horizon's immunity range, it requires a venous blood draw at a clinic or via a home nurse visit, with results due back within 3 days.
The score reflects strong clinical depth and a solid results and follow-up mark, since a doctor reviews the results, offset by a weaker value-for-money score given the above-median price. Collection convenience also scores modestly because there is no at-home finger-prick option. Blue Horizon Medicals is rated 4.2 on Trustpilot from 395 reviews, uses UKAS ISO 15189 partner labs, and has traded since 2009.
This suits anyone who wants a single test covering measles, mumps, rubella and varicella immunity together, rather than ordering these checks separately. It is a reasonable choice if breadth across these four infections matters more to you than price.
If cost is the priority, this is one of the more expensive options among the similarly sized immunity tests we track, running around 21% above the group median, so it is worth checking whether a narrower profile would cover what you need instead. It also requires a venous blood draw at a clinic or nurse visit rather than an at-home finger-prick kit.
This is a blood test collected by venous draw, either at a clinic or through a nurse home visit; there is no at-home finger-prick option. Results are typically available within 3 days, and a doctor reviews them before they reach you.
Four immunity markers, measles, mumps, rubella and varicella, are checked in this panel for £120.25, with a doctor reviewing your results within 3 days. It costs about 21% more than the £99.13 median for the 24 similarly sized immunity tests we track, making it a premium option within this group. The upside is a wider immunity check than smaller profiles in this range, covering all four infections in one test.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
4 biomarkers, placing it in the 87th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 3 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£120.25 against a median of £99.13 for the 24 similarly sized immunity tests we track (+21%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
